Inici › Limfoma difús de cèl·lules B grans › Califòrnia › Los Angeles
Assaigs clínics de Limfoma difús de cèl·lules B grans a Los Angeles, CA
17 estudis de Limfoma difús de cèl·lules B grans busquen participants en centres de Los Angeles i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutantFase 2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
ReclutantFase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ReclutantFase 3
- Cedars-Sinai Medical Center ( Site 0115), Los Angeles
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
ReclutantFase 3
- David Geffen School of Medicine at UCLA, Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutantFase 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ReclutantFase 1/2
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
ReclutantFase 2
- Valkyrie Clinical Trials, Los Angeles
A Study of ARC-02 in B-cell NHL
ReclutantFase 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutantFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
ReclutantFase 1
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutantFase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutantFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
ReclutantFase 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ReclutantFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
ReclutantFase 1/2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ReclutantFase 2
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutantFase 1
- University of Southern California, Los Angeles
Assaigs de Limfoma difús de cèl·lules B grans en altres ciutats
- New York City, NY21 estudis
- Baldwin Park, CA19 estudis
- Chicago, IL18 estudis
- Houston, TX17 estudis
- Boston, MA16 estudis
- Milwaukee, WI16 estudis
- Nashville, TN15 estudis
- Portland, OR15 estudis
- Philadelphia, PA15 estudis
- Durham, NC14 estudis
- Dallas, TX13 estudis
- Seattle, WA12 estudis
Altres estudis a Los Angeles
- Càncer de pulmó de cèl·lules no petites87 estudis
- Càncer (tots els tipus)73 estudis
- Càncer de mama72 estudis
- Càncer de pròstata61 estudis
- Càncer colorrectal59 estudis
- Càncer metastàtic57 estudis
- Càncer d'ovari50 estudis
- Càncer de pulmó45 estudis
- Carcinoma de cèl·lules escamoses de cap i coll42 estudis
- Càncer de pàncrees35 estudis
- Càncer d'endometri34 estudis
- Melanoma34 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.